Literature DB >> 23137516

Identification of a hidden outbreak due to the spread of a VIM-3-producing, extensive drug-resistant Pseudomonas aeruginosa (XDRPA) clone at a regional hospital in Taiwan.

J C Shu1, L H Su, J H Chia, S H Huang, Y C Kao, S C Lee, T L Wu.   

Abstract

A review of the annual prevalence of Pseudomonas aeruginosa at a regional hospital in Taiwan revealed a significant increase in the incidence of extensive drug-resistant P. aeruginosa (XDRPA) from 2∙1% in 2003 to 5∙8% in 2007. The first XDRPA isolate was recovered in 2001 from the emergency ward. The widespread dissemination of XDRPA isolates to more than 10 other wards was discovered the following year. Six pulsotypes of 67 XDRPA isolates from 2006 onwards were identified and 91% were a single strain, suggesting the existence of a hidden outbreak. Prior to the recognition of the outbreak, the majority of cases were not considered to be healthcare-associated infections until molecular evidence was provided. A cohort measure was launched by the infection control practitioners that effectively controlled the outbreak. Patients with XDRPA were mostly referred from neighbouring long-term care facilities, which may have been the reservoir of the XDRPA clone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23137516      PMCID: PMC9151623          DOI: 10.1017/S095026881200204X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  8 in total

Review 1.  The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technology.

Authors:  M A Pfaller; L A Herwaldt
Journal:  Clin Infect Dis       Date:  1997-10       Impact factor: 9.079

2.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

3.  Declining emergency department visits and costs during the severe acute respiratory syndrome (SARS) outbreak.

Authors:  Hsien-Hao Huang; David Hung-Tsang Yen; Wei-Fong Kao; Lee-Min Wang; Chun-I Huang; Chen-Hsen Lee
Journal:  J Formos Med Assoc       Date:  2006-01       Impact factor: 3.282

4.  Impact of an outbreak of severe acute respiratory syndrome on a hospital in Taiwan, ROC.

Authors:  M C Tsai; J L Arnold; C C Chuang; C H Chi; C C Liu; Y J Yang
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

5.  The changing epidemiology of cystic fibrosis.

Authors:  S C FitzSimmons
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

6.  Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens.

Authors:  Lin-Hui Su; Jonathan T Ou; Hsieh-Shong Leu; Ping-Cherng Chiang; Yueh-Pi Chiu; Ju-Hsin Chia; An-Jing Kuo; Cheng-Hsun Chiu; Chishih Chu; Tsu-Lan Wu; Chien-Feng Sun; Thomas V Riley; Barbara J Chang
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

7.  Pseudomonas aeruginosa bacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes.

Authors:  Mi Ae Yang; Jina Lee; Eun Hwa Choi; Hoan Jong Lee
Journal:  J Korean Med Sci       Date:  2011-04-21       Impact factor: 2.153

8.  Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).

Authors:  Jwu-Ching Shu; Ju-Hsin Chia; Leung-Kei Siu; An-Jing Kuo; Shu-Huan Huang; Lin-Hui Su; Tsu-Lan Wu
Journal:  Int J Antimicrob Agents       Date:  2011-11-10       Impact factor: 5.283

  8 in total
  1 in total

1.  First Italian outbreak of VIM-producing Serratia marcescens in an adult polyvalent intensive care unit, August-October 2018: A case report and literature review.

Authors:  Maria Rosaria Iovene; Vincenzo Pota; Massimiliano Galdiero; Giusy Corvino; Federica Maria Di Lella; Debora Stelitano; Maria Beatrice Passavanti; Maria Caterina Pace; Aniello Alfieri; Sveva Di Franco; Caterina Aurilio; Pasquale Sansone; Vettakkara Kandy Muhammed Niyas; Marco Fiore
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.